StockUnited StatesNasdaqGS

BCRX

BioCryst Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

8.115USD

-0.6900 (-7.84%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 8.12

P/E—

Dvd Ind Yld—

P/B—

P/S2.2

Curr EV/T12M EBITDA6.3

Mkt Cap (USD)2.1B

Curr EV (USD)2.7B

Per Share Data

EPS T12M-1.50

DPS—

Bk Val Per Sh-1.78

Rev/Sh3.55

Cash/Sh1.38

Curr Shares Out255.5M

FCF/Sh1.41

Cash Flow Analysis

P/CF5.5

Curr P/FCF5.6

CF/NI-1.0

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales40.0%

Eff Interest Rate23.6%

Growth Potential

Dil EPS 1Y Gr381.4%

Cap 1Y Gr26.0%

BPS 1Y Gr76.3%

R&D To Sales21.0%

Retention Rate100.0%

Rev 1Y Gr94.1%

FCF 1Y Gr749.0%

Assets 1Y Gr4.8%

Profitability

EBITDA-0.3B

EBIT-0.3B

Operating Margin-33.3%

Pretax Margin-40.5%

Net Margin-40.9%

ROA-75.8%

ROE87.8%

ROC—

Asset Turnover1.85

Structure

Current Ratio2.32

Quick Ratio2.22

Debt/Assets150.0%

Debt/Com Eq-184.2%

Net Debt/EBITDA-2.19

Tot Debt/Capital218.8%

Gross Margin97.8%

EBIT/Int Exp-4.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.